Introduction
Type 1 diabetes is an autoimmune disease resulting from inflammatory cell and cytokine-mediated destruction of insulin-producing pancreatic beta cells, [1] [2] [3] [4] [5] [6] in part through apoptotic pathways. 7, 8 Although islet cell transplantation could potentially provide long-term benefits for treatment of this disease, significant constraints for the successful use of this method rely on the allograft tolerance by the recipient. Immunosuppressive drug therapy in combination with islet cell transplantation is not optimal for this purpose, since this procedure is often associated with deleterious side-effects such as toxicity and frequent infections. 9, 10 Therefore, treatment of diabetes requires more practical and long-term solutions.
Gene therapy approaches using viral vectors could be used to manipulate the islet cells genetically by introducing immunosuppressive genes before transplantation. As a first step, it is important to identify the appropriate vec-transgenes with heterologous promoter in place of AAV open reading frames (rep and cap). In this report we demonstrate the transduction of pancreatic islet cells with AAV vectors encoding bacterial ␤-galactosidase enzyme or enhanced green fluorescent protein (EGFP) as reporter gene. Dispersed porcine and rat islet cells can be transduced by AAV vector, with an efficiency of 47% and 38%, respectively. In particular porcine islet insulin producing beta cells were transduced with an efficiency of 39%. Intact rat islet cells were transduced with an efficiency of 26% as estimated by FACS analysis following transduction with an AAV vector encoding EGFP. Transduction of intact rat islets with an AAV vector did not alter glucose-induced insulin secretion. AAV vector transduction was higher in transformed islet cell lines INS-1 and RIN m5F with an efficiency of 65% and 57%, respectively. These new results suggest that AAV vectors will provide an improved method of gene delivery to pancreatic islets and isolated pancreatic beta cells. Gene Therapy (2000) 7, 1553-1561.
tor system to deliver the target genes to islet cells. In this regard several viral vectors have been tested for their efficacy to transduce islet cells. Adenovirus vectors [11] [12] [13] and lentivirus vectors [14] [15] [16] have been shown to transduce pancreatic islet cells efficiently. However, the efficacy of AAV vector transduction to islet cells has not been demonstrated to date. AAV have several properties that make them attractive for use in gene transfer technology. AAV vectors are derived from AAV type2 virus, which is a non-pathogenic, replication-defective parvovirus, [17] [18] [19] and can integrate into host genome at a specific locus. 20, 21 A unique feature of this virus is the inverted terminal repeat (ITR) sequences at both termini of the genome, which are the only elements required in cis for replication, encapsidation and integration of the viral genome. 18, 22 Therefore, AAV vectors are constructed by removing all viral genes (rep and cap, Figure 1 ) between the two ITRs and replacing them with the gene of interest. 23 AAV vectors have been shown to transduce both dividing and nondividing cells, and provide long-term expression by stable integration. [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] In this study, we used AAV vectors carrying the ␤-gal or EGFP reporter genes and demonstrated for the first time that AAV vec- tors can be successfully used to transduce insulinsecreting pancreatic islet beta cells and intact islets. Since, stable long-term expression of immunosuppressive or anti-inflammatory genes by the genetically modified tissue is necessary for graft survival, transduction of islet cells with AAV vectors carrying these genes could provide a safe, non-toxic method to protect allogeneic islet cell graft.
Results

AAV vectors
ITRs of AAV are highly GC rich and can undergo mutations, which abolish their ability to be rescued from the bacterial plasmid. Therefore, integrity of AAV ITRs in the plasmids was routinely tested by restriction digestion with SmaI. Also the ability of ITRs to replicate in presence of AAV Rep protein and adenovirus infection was tested by cotransfecting 293 cells with one of the AAV vector plasmid and pAd/AAV (which provides AAV Rep protein), and infecting with adenovirus type5. In replication permissive conditions AAV vectors rescued from the bacterial plasmids undergo multiple rounds of replication, which yield single strand (SS) DNA, replicative form monomer (RFM) DNA, and replicative form dimer (RFD) (Figure 2 ). SS DNA is a unit length vector DNA, and RFM and RFD are replicative intermediates. Existence of RFM in a replicative permissive condition is an indication that the vector can be rescued and replicate, thus confirms the integrity of ITRs. Figure 2 is a typical example of one such experiment showing the SS DNA and RFM DNA.
Southern analysis of CSCl 2 gradient fractions was performed to locate the AAV vectors (Figure 3a) . Generally AAV vectors banded between densities 1.36 to 1.44 g/cc. Fractions containing the AAV vectors were pooled and dialyzed/concentrated. DNA prepared from 10 l from the pooled sample was titrated against known standard (Figure 3b) particles/ml (P/ml). In case of ACS␤gal, approximately 500 particles per cell were required to transduce one 293 cell.
AAV vector-mediated gene transfer into porcine and rat islet cells and rat beta cell lines To test the transduction efficiency of the AAV vector in islet cells, we used an AAV vector ACS␤gal (Figure 1 ), carrying bacterial ␤-galactosidase controIled by human cytomegalovirus (CMV) promoter. CMV promoter has been commonly used for constitutive and high-level transgene expression in varieties of cell lines and tissues. CMV promoter has been successfully used in islets for adenovirus and lentivirus vector mediated transgenes expression. In order to test the efficacy of AAV vector transduction in nondividing primary islet cells, islets were first isolated by collagenase treatment and then were dispersed by trypsinization/collagenase treatment. The individual islet cells were cultured overnight to recover from the trypsinization and exposed to ACS␤gal (5 × 10 3 particles/ml). Two days following transduction cells were transferred to poly d-Lys-coated chamber slides and cultured for 2 more days. Cells were fixed and stained for ␤-gal activity. In order to estimate the transduction efficiency of AAV vector, we enumerated the total num- ber of cells and number of ␤-gal positive cells from each of five different fields and these are summarized in Table  1 . Results show that porcine islet cells could be transduced at 47% ( Figure 5a ) and rat islet cells up to 38% ( particles per islet were used, and the efficiency was increased to 26% when the 1 × 10 7 particles per islet were used ( Figure 6 ).
We also performed Western blot analysis to test AAVmediated transgene expression in porcine pancreatic islets and two beta cell lines, INS-1 and RIN m5F cells. On the other hand, the cells transduced with ACSM12-LO and harvested on day 2 gave a 12-LO specific band, suggesting that the 12-LO specific bands in the other lanes (day 1-21, Figure 7b and c) are due to AAVmediated transgene expression and not due to upregulation of endogenous 12-LO by vector transduction protocols. In these cells basal endogenous 12-LO levels are low. The peptide antibody used can crossreact with rat endogenous 12-LO. We did not detect any endogenous 12-LO protein under the conditions we used. These data clearly show evidence for AAV-mediated transgene expression in islets and two beta cell lines, indicating that nondividing pancreatic islet cells can be successfully transduced with AAV vectors.
Figure 7 Western blot analysis for AAV vector mediated transgene expression in porcine islets and two beta cell lines Rin m5F, and INS 1 cells. (a) Porcine islets (dispersed with collagenase and cultured overnight) or 293 cells were transduced (+) with ACSbgal at an multiplicity of infection of 10. Four days after transduction cells were harvested and protein extracts were analyzed by Western blot using mouse anti-␤-gal monoclonal antibody. Porcine islets or 293 cells transduced with ACSN (−)
AAV vectors transduce pancreatic ␤ cells Pancreatic islets contain three major cell types alpha, beta and delta. In type 1 diabetes it is the insulin-secreting
Gene Therapy beta cells that are destroyed by the inflammatory cells. Therefore, any gene therapy protocols for islets to treat type 1 diabetes would optimally target the beta cells. We wanted to test if the pancreatic beta cells are receptive to AAV vector-mediated transgene expression. Transduction of AAV vector into pancreatic beta cells was demonstrated by immunofluorescence. Dispersed porcine islet cells were exposed to ACS␤gal at 5 × 10 3 particles per cell. Two days following the transduction, cells were trypsinized and plated on poly-D lysine coated plates. Another 2 days later cells were fixed with 4% paraformaldehyde and analyzed by double-immunofluorescence using mouse monoclonal anti-␤gal antibody and guinea pig anti-porcine insulin antibody (beta cell specific) followed with fluorescence conjugated antimouse antibody and rhodamine-red conjugated antiguinea pig antibody. The cells were examined using fluorescence microscopy using appropriate filters and photographed. Red cells in Figure 8a are the insulin positive beta cells and the green cells in Figure 8b are the ␤gal-positive AAV vector infected cells. Beta cells that are positive for both insulin and AAV vector posses both red and green fluorescence, and they appear yellow when observed using double filter (Figure 8c ). In order to estimate the transduction efficiency of AAV vector in beta cells, we enumerated the red cells (insulin positive beta cells) and the yellow cells (insulin positive beta cells infected with AAV vector) from five different fields. The results show that 39% of the beta cells were transduced with AAV vector (Table  1 ). These data indicate that AAV vectors can target the insulin producing beta cells of porcine pancreatic islets.
Discussion
An attractive goal is to develop pancreatic islets with an altered genetic make up, which can ultimately be used for islet transplantation to treat type 1 diabetes. It is currently thought that porcine islets could provide a way to reverse type 1 diabetes if the immunologic obstacles could be overcome. We have successfully demonstrated that adeno-associated virus vectors can transduce ␤-gal and mouse 12-LO genes into porcine and rat islet beta cells upto 47% and 39%, respectively. The rates of transduction were even higher, up to 65%, in isolated beta cell lines. Transduction efficiency was 26% in intact rat islet cells. The likely reason for relatively lower transduction efficiency in intact islet cells is that the vector was not accessible to the deeply buried cells in tightly associated intact islets. One possible way to enhance the transduction efficiency of AAV vector into islets is by infusion of vector into the pancreas through arteries which exposes the inner part of the tissue to the vector and may provide better transduction efficiency. However, for immunomodulation of islets before transplantation 26% transduction efficiency may be enough to protect the graft expressing the immunoprotective proteins/cytokines. Recently it has been demonstrated that islet graft transduced with a lentiviral vector encoding IL-4 with an efficiency of approximately 5% was enough for graft survival for at least 12 weeks. 14 We also observed that glucose induced insulin secretion in AAV vector transduced islets was not altered (data not shown) and transduction did not induce apoptosis in islet cells (data not shown) as estimated by TUNEL assay. Therefore AAV vectors should not affect the functional or structural integrity of the beta cell. Recent studies have demonstrated the ability of AAV vectors to transduce a given cell type depends on the presence of membrane-associated heparan sulfate proteinglycan (HSPG). [35] [36] [37] A recent report has shown the presence of HSPG on human pancreatic beta cells. 38 Using a immunofluorescence technique, we have demonstrated the presence of HSPG on rat islet beta cells ( Figure  9 ). In several cell types such as muscle, neuronal and lung epithelial cells, AAV have been shown to integrate and persist for several months. We would anticipate that AAV vectors could do the same in islet cells. However, we are currently evaluating the duration of AAV vector mediated transgene expression and integration status of AAV vectors in islet cells.
Successful use of gene therapy protocols for diabetes treatment will be dependent on identifying the target genes that need to be corrected or interrupted. Although several loci have been associated with the disease, no gene has been identified to date. Therefore identifying target genes will be essential to develop appropriate gene therapy protocols for treatment of diabetes. Immunomoa b
Figure 9 Immunofluorescence showing the expression of heparan sulfate proteoglycan on rat islet B cells. Double immunofluorescence was performed on dispersed rat islet cells plated on eight-well chamber slides coated with poly-D-lysine. Cells were treated with anti-heparan sulfate proteoglycan monoclonal antibody and guinea pig anti-insulin antibody for 1 h at room temperature. After incubation and washing, cells were treated with second antibodies: fluorescence-labeled anti-mouse IgG and rhodamine labeled anti-guinea pig IgG. Following 1 h incubation at ambient temperature, cells were washed and observed using fluorescent microscope with appropriate filters and photographed. (a) Red filter shows insulin-producing beta cells; (b) green filter shows the expression of heparan sulfate proteoglycan on the same insulin producing beta cells seen in panel a.
dulation of the local environment of an islet allograft 39, 40 and genetic manipulation of the islet cells before transplantation have been shown to mediate graft survival. 14, 16 Recent evidence suggests that elimination of the 12-lipoxygenase (12-LO) gene can protect islets from inflammatory cytokine and toxin-induced damage. 41 Therefore gene targeting of 12-LO could provide one way of protecting islets. In addition, another key factor will be development of an efficient and safe gene transfer system that can persist for a long time without inducing inflammatory responses. Although adenovirus vectors transduce efficiently, 12,13 they do not integrate into the host genome and therefore can not provide long-term gene expression. In addition adenovirus are known to elicit immune reactions that trigger elimination of adenovirus vector transduced cells. 42, 43 Retrovirus vectors have been shown to transduce dividing fetal islets efficiently, 44 but they can not transduce nondividing adult pancreatic islet cells. Lentiviral vectors derived from human immunodeficiency virus can transduce nondividing cells and provide long-term gene expression. 34, 45 Also lentiviral vectors can transduce islet cells very efficiently. [14] [15] [16] Islet grafts transduced with lentiviral vector encoding IL-4 protect the transplant from insulitis. 14 AAV vectors are likely to be safe, as they are not known to cause any clinical symptoms. AAV vectors can transduce both dividing and nondividing cells and provide long-term gene expression by stable integration. However, AAV vectors accommodate only 4-4.5 kb foreign DNA, this feature precludes its use for larger genes.
In summary, our results indicate that AAV vectors can transduce islet beta cells. These data suggest that AAV vectors possess all the features that make them attractive for use as a means to deliver transgenes to islet cells for diabetes gene therapy.
Materials and methods
Cells
Rin m5F cells (ATCC, Manassas, VA, USA) were cultured in RPMI medium supplemented with 10% fetal calf serum, 2 mm glutamine and antibiotics. INS-1 cells (gift from Dr Christopher Rhodes, Pacific Northwest Institute, Seattle, WA, USA) were cultured in RPMI medium supplemented with 10% fetal calf serum, 2 mm glutamine, 50 m 2-mercaptoethanol, 1 mm pyruvic acid, 10 mm HEPES, and antibiotics. 293 Cells were cultured in DME medium supplemented with 10% fetal calf serum, 2 mm glutamine and antibiotics. Porcine islets were kindly pro-vided by Dr Steve Hager (Neocrine, Irvine, CA, USA). Rat islets were prepared as reported previously. 46 Porcine and rat islets were cultured in RPMI medium supplemented with 10% fetal calf serum, 2 mm glutamine and antibiotics. Studies were approved by the Animal Review Committee.
Construction of AAV vectors
Plasmid pSPAAV was constructed by subcloning a full length wild-type adeno-associated virus type 2 DNA analogue from pSub201 into a plasmid pSP-PL which was generated by removing 62 base pair (HindIII-EcoRV) fragment from pSP72 (Promega, Madison, WI, USA). pSPAAV was used to construct AAV vectors. pACS was generated by replacing rep and cap orf of pSPAAV for a 1.3 kbp SalI fragment from pCEP4. The resulting plasmid pACS contains pSP72 plasmid backbone with CMV promoter, polylinker and SV40 polyA flanked by AAV ITRs.
Plasmid pACSM12-LO encoding a mouse 12-lipoxygenase was generated using pACS. An approximately 2 kbp full-length, mouse 12-LO, cDNA (gift from Dr Colin Funk, University of Pennsylvania) was excised as NheI fragment from pARS (described elsewhere) and subcloned at the NheI site of pACS. Orientation of the insert was tested by restriction digestion analyses and expression of mouse 12-LO confirmed by transient transfection followed by Western immunoblotting. Plasmid pACS␤gal encoding a bacterial ␤-galactosidase enzyme was constructed using pACS. B-galactosidase gene along with SV small T antigen polyA was obtained from a plasmid pSV-␤gal (Promega), first SalI site was cut and blunt ended by fill-in reaction, then a 3.8 kb fragment was isolated by HindIII digestion. The AgeI site of plasmid pACS was cut and blunt ended by fill-in reaction. Then digested by HindIII enzyme to remove a 430-bp fragment (SV40 polyA signal). A 3.5 kb fragment was isolated and ligated to 3.8 kb SalI(blunt)-HindIII fragment from pSV␤gal. The resulting plasmid contains the ␤-gal gene driven by CMV promoter flanked by AAV ITRs. Plasmid pACSN is a modification of pARSN, which was generated as follows. A 3.1 kb XbaI-BglII fragment from pREP9 (Invitrogen) was first subcloned into XbaI-BamHI site of pSP72. The resulting plasmid pSTGI contains RSV promoter, polylinker, SV40 polyA and neomycin resistance gene with TK polyA. Then, SV40 early promoter, approximately 400 bp EcoRI-HindIII fragment (blunt ended) was inserted at ClaI (blunt ended) site of pSTGI to generate pSTGII. Plasmid pARSN was generated by replacing rep and cap orf of SPAAV for a 3.5 kb XbaI-EcoRV fragment from pSTGII. Plasmid pACSN was constructed by substituting CMV promoter (from pCEP4, Invitrogen) for RSV promoter. Plasmid pACSNEGFP was constructed by inserting a 0.78 kb HindIII-NotI fragment from pEGFP-1 (Clontech) into HindIII-NotI site of pACSN. All plasmids were constructed using standard cloning methods. All the restriction enzymes were obtained from New England Biolabs.
Integrity of AAV ITRs was routinely tested by restriction digestion with SmaI. Also the ability of ITRs to replicate in the presence of AAV Rep protein and adenovirus infection was tested by cotransfecting the 293 cells with one of the AAV vector plasmid and pAd/AAV (which provides AAV Rep protein), and infecting with adenovirus. Two days after Hirt DNA extracts were prepared and analyzed by Southern hybridization using Production of AAV vector stock AAV vectors were produced in 293 cells by calcium phosphate co-transfection method using pAd/AAV as helper plasmid, and purified by double banding on CsCl 2 density gradient centrifugation. The following protocol describes the method used for AAV vector preparation. 293 Cells grown to 80% confluent in 20 15-cm dishes were infected with Ad5 at an MOI of 5 in 15 ml of serum-free medium. Cells were incubated at 37°C for approximately 2 h. Then fetal bovine serum (0.75 ml) was added to the final concentration of 5%. Twenty-five micrograms of AAV vector plasmid (ACS␤gal or ACSM12-LO or ACSN or pACSNEGFP) and 25 g of pAd/AAV per 15-cm plate were used. Plasmid was mixed with 1 ml of 250 mm CaCl 2 and then added to 1 ml of 2× HBS (50 mm HEPES, 280 mm NaCl, 1.5 mm Na 2 HPO 4 , pH 7.05) drop wise and mixed gently by bubbling. DNA was allowed to precipitate for 10 min at room temperature and then added on to the cells drop wise. After 10-16 h of transfection/infection, medium was replaced with fresh 20 ml of DME medium supplemented with 10% fetal bovine serum without antibiotics. After 48 h of posttransfection/infection, cells were dislodged by tapping and collected in 10 mm Tris, pH 8.0, with 5 mm MgCl 2 , washed once and resuspended in the same buffer. Cells were lysed by freezing and thawing four times in a dry ice-ethanol bath. Treated with Dnase I (25 U/ml) for 1 h at 37°C. Deoxycholic acid was added to the final concentration of 0.1% and treated with trypsin (0.125%) at 37°C for 1 h. Cell debris was removed by centrifugation at 3000 r.p.m. on a tabletop centrifuge. Supernatant was collected and centrifuged at 15 000 r.p.m. (30 000 g) for 2 h. The pellet was dissolved in Krebs Ringers phosphate buffer (KRPB) with CsCl 2 to density 1.39 g/ml and centrifuged in an SW40 rotor (Beckman) at 35 000 r.p.m. for 30-35 h. AAV vector band was noticed below the adenovirus band. One milliliter fractions were collected from the top of the gradient. Fractions with density 1.36 to 1.44 were pooled and adjusted to 1.38 g/ml with CsCl 2 and centrifuged again in a SW40 rotor at 35 000 r.p.m. for 30-35 h. One milliliter fractions were collected. 10-20-l aliquots from each fraction were collected and added NaOH, SDS and 2-mercaptoethanol added to the final concentration of 100 mm, 1%, and 50 mm, respectively. Samples were heated to 65°C for 10 min and resolved on 0.8% alkaline gel. Southern hybridization was performed as mentioned below. The peak fractions containing AAV vector genome was filter/concentrated using amicon concentrator with 30 000 molecular weight cut off with KRPB containing 5% glycerol. Generally 2 ml of vector stocks were obtained from 20 15-cm plates. All vector stocks were heat inactivated at 56°C for 0.5-1 h to remove any residual adenovirus contamination. Purified vector stocks were stored at −70°C for future use.
Characterization of vector stock AAV vectors titer was determined as the number of particles containing full-length vector genome by Southern hybridization and expressed as number of particles per milliliter. An aliquot (10 l) of purified vector diluted to 200 l with 10 mm Tris, pH 8.0, containing 0.5% SDS and treated with 100 g/ml of proteinase K at 37°C for 1 h.
Sample was transferred to an Amicon concentrator (1 ml, 30 000 molecular weight cut off), dialyzed/concentrated to 10 l. Sodium hydroxide and SDS was added to the final concentration of 100 mm and 1%, respectively. For titration of ACSM12-LO, known amounts of 2 kb fulllength 12-LO fragment treated similarly to the vector was used as a standard. Samples were resolved by electrophoresis on 0.8% alkaline agarose gel. DNA was transferred to Hybond N+ membrane (Amersham) using 0.4 N NaOH as the transfer solution. Hybridization was performed using ExpressHyb hybridization solution (Clontech) according to the manufacturer's protocol. Two kb full length cDNA for ACSM12-LO and 3.4 kb full length cDNA for ACS␤gal were labeled with 32 P by random primed labeling kit (Boehringer, Mannheim, Germany) and used as probes. Following Southern hybridization, the number of single-strand vector DNA in the purified stock was determined compared with the standards, using Phosphorimager analysis.
Western immunoblotting
Protein extracts were prepared by lysing the cells in PBS (pH 7.3) containing 1% Triton X-100, 0.1% SDS, 1 mm PMSF, and 50 m leupeptin. Lysates were centrifuged for 10 min and supernatants were used for Western blot analyses. Protein extracts were resolved on 8% polyacrylamide gel (SDS-PAGE) and the proteins were transferred to Immobilon membrane using semi-phor transfer apparatus (Hoefer-Scientific Instruments). The blots were incubated either with rabbit polyclonal antibody (1:1000) raised against a peptide spanning 646-662 of porcine leukocyte 12-LO, or mouse anti-␤-galactosidase monoclonal antibody, 1:2500 (Gibco-BRL). Blots were then washed and incubated with appropriate second antibodies (goat anti-rabbit IgG or goat anti-mouse IgG) conjugated with horseradish peroxidase, 1:10 000 (NEB). The blots were developed using ECL Western blotting detection system (Amersham Life Sciences). Peptide antibodies, made against the porcine leukocyte type 12-LO, highly crossreacts with mouse and rat counterpart. 46 Processing porcine and rat islets for transduction To disperse the porcine and rat islet cells, we followed the protocol described by Ju et al 15 with a little modification. Islets were washed with PBS once and were resuspended in PBS (500 islets per milliliter) containing 0.1% collagenase and 0.05% trypsin and 2 mm EDTA and incubated at 37°C on an end to end shaker for 5 min. Then the islet suspension was placed on ice for 5-10 min to allow the undigested islets to settle and the supernatant containing dispersed islet cells was collected. Digestion was repeated to disperse further the undigested islets settled at the bottom of the tube. Dispersed islet cells were pooled and washed once and cultured in appropriate medium overnight.
␤Galactosidase staining Histochemical staining for ␤-gal activity assessed AAV vector mediated ␤-gal gene transfer. RIN m5F, INS-1, 293 or dispersed islet cells were exposed to ACS␤gal at 5 × 10 3 particles per cell. Three days following the transduction of Rin m5F, INS-1 or 293 cells, and 4 days following the transduction of dispersed islets, cells were fixed with 4% paraformaldehyde in PBS at room temperature for 30 min. Plates were washed and incubated with 0.2% X-gal in PBS (pH 6.8) containing 2 mm MgCl 2 , 5 mm potassium ferocyanide (K 4 Fe(CN) 6 .3H 2 O), and 5 mm potassium ferricyanide (K 3 Fe(CN) 6 ). Cells expressing ␤-gal turn indigo. The reaction was carried out at slightly acidic pH to suppress the endogenous galactosidase activity. Photographs were taken using photoimaging system.
AAV vector transduction
Rin m5F, INS-1 or 293 cells were grown to 60% confluence in 48-well plates, and 5000 dispersed porcine or rat islet cells were exposed to ACS␤gal at 5 × 10 3 particles per cell. For Rin m5F, INS-1 and 293, cells were either replaced with fresh medium or harvested for protein extraction and Western immunoblot analysis the following day. For islet cells, 2 days following transduction the cells were trypsinized (0.125% trypsin and 2 mm EDTA in PBS) for 5 min, washed with respective culture medium and plated on to eight-well chamber slides coated with poly D-lysine. Finally 4 days following transduction cells were fixed for X-gal staining or harvested for protein extraction and Western immunoblot analysis. To determine time course for AAV vector-mediated transgene expression, Rin m5F and INS-1 cells were grown to 60% confluence and transduced with ACSM12-LO at 5 × 10 3 particles per cell. Cells were harvested at different interval of time (1-21 days) and processed for Western immunoblot analysis.
FACS analysis
For the detection of AAV-mediated EGFP expression in intact rat islets: Three days following the transduction, islets were washed with PBS once and were resuspended in PBS containing 0.1% collagenase and 0.05% trypsin and 2 mm EDTA and incubated at 37°C with shaking in an end to end shaker for 5 min. Then islet suspension was placed on ice for 5-10 min to allow the undigested islets to settle and the supernatant containing dispersed islet cells was collected. Cells were resuspended in KRBB (Krebs-Ringer bicarbonate buffer) containing 10 mm HEPES, and 0.5% BSA and passed in and out 30 times with 1 ml pipet tip. Remaining aggregates were allowed to settle by gravity for 5 min and supernatant containing mainly single cells was used for FACS analysis. FACSCalibur (Becton Dickinson) with an argon laser tuned to 488 nm at 15 mW output was used. 10 4 cells were analyzed at 150-200 cells/s. Untransduced islet cell were used as the control. Number of cells plotted against the log fluorescence reflected the EGFP content in the cell. Data acquisition and analysis was performed using the CellQuest program.
